Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 36.66
-1.74 %
$ 4.53 B
Market Cap
-8.61
P/E
GH - COST OF REVENUE
Cost of Revenue GH - Guardant Health, Inc.
227 M
LAST VALUE
35.91%
2 YEAR CAGR
39.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR